Subscribers
Non-subscribers
- Purchase article PDF [£27 + taxes]
- Purchase article PDF member offer [£5 + taxes]
Free access
Communication
Dalton Trans., 2008, 6364 - 6367, DOI: 10.1039/b815404j
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease
Lauren E. Scott, Brent D. G. Page, Brian O. Patrick and Chris Orvig
Selective design modifications of specifically substituted 3-hydroxy-4(1H)-pyridinones show possibly advantageous ring freedom while maintaining metal-binding ability and antioxidant capacity, moving toward an efficient potential treatment for Alzheimer's disease.

